Company Filing History:

14 out of 4,442

Eli Lilly and Company

patents

1 out of 32

Université Louis Pasteur

where one patent can have more than one assignee

Years Active: 1992-2004

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6800651 - Potentiators of glutamate receptors (2004-10-05),

2. 5925680 - Synthetic excitatory amino acids (1999-07-20),

3. 5882671 - Anxiolytic agents (1999-03-16),

4. 5843997 - Excitatory amino acid receptor antagonists (1998-12-01),

5. 5750566 - Synthetic excitatory amino acids (1998-05-12),

6. 5739164 - Pharmaceutical compounds for the treatment of CNS diseases (1998-04-14),

7. 5717109 - Excitatory amino acid receptor antagonists (1998-02-10),

8. 5670516 - Excitatory amino acid receptor antagonists (1997-09-23),

9. 5661184 - Psychiatric agents (1997-08-26),

10. 5589501 - Pharmaceutical compounds (1996-12-31),

11. 5576323 - Excitatory amino acid receptor antagonists (1996-11-19),

12. 5473077 - Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate (1995-12-05),

13. 5196421 - Excitatory amino acid receptor antagonists in methods for the use thereof (1993-03-23),

14. 5153196 - Excitatory amino acid receptor antagonists and methods for the use (1992-10-06),

Title: Unveiling the Inventive Mind of Darryle D Schoepp

Introduction:

In the realm of innovative minds, inventor Darryle D Schoepp stands out as a prolific contributor to the world of patents and research. Hailing from Indianapolis, IN (US), Darryle has garnered an impressive number of patents and made significant advancements in the field of neuroscience and pharmacology.

Latest Patents:

Darryle D Schoepp's latest patents showcase his expertise in developing compounds that impact neurological and psychiatric disorders. His inventions include "Potentiators of glutamate receptors," focusing on enhancing metabotropic glutamate receptor function, and "Synthetic excitatory amino acids," aimed at treating various neurological and psychiatric conditions.

Career Highlights:

Throughout his career, Darryle D Schoepp has been associated with renowned companies such as Eli Lilly and Company, where he has showcased his inventive prowess in pharmacological research. Additionally, his affiliation with Universite Louis Pasteur highlights his global impact and collaborative efforts in advancing scientific discoveries.

Collaborations:

In his innovative journey, Darryle D Schoepp has collaborated with esteemed professionals in the field, including James Allen Monn and Joseph P Tizzano. These collaborations have not only enriched his research endeavors but have also led to groundbreaking developments in neuroscience and pharmacology.

Conclusion:

Inventor Darryle D Schoepp's trailblazing work in the realm of patents and inventions exemplifies his dedication to advancing scientific knowledge and improving healthcare outcomes. His contributions in the development of compounds for neurological disorders underscore his commitment to innovation and transformative research in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.